Know Cancer

or
forgot password
  • cancer clinical trials in loma linda, CA

  • Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor
    PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Multiple Myeloma
    S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed
    Veterans Affairs Medical Center - Loma Linda (Pettis)
    Loma Linda, California 92357
    Colorectal Cancer
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
    Loma Linda University Medical Center

    Trial Locations
    Loma Linda University Medical Center
    LLU Faculty Medical Offices
    LLU Faculty Meidical Offices
    Ovarian Neoplasms
    SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism
    Jerry L. Pettic VA Medical Center
    Loma Linda, California
    Pulmonary Embolism
    VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
    Loma Linda Cancer Research Institute
    Loma Linda, California 92354
    Mantle Cell Lymphoma
    Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy
    LLUMC for Molecular Biology and Gene Therapy
    Loma Linda, California 92354
    Prostate Cancer
    Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Metastatic Cancer, Sarcoma
    Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Lymphoproliferative Disorder
    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
    Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Anemia, Sickle Cell
    Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Leukemia
    Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Lymphoma
    Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Sarcoma
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Pancreatic Cancer
    Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
    Veterans Affairs Medical Center - Loma Linda (Pettis)
    Loma Linda, California 92357
    Lung Cancer
    FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer
    Veterans Affairs Medical Center - Loma Linda (Pettis)
    Loma Linda, California 92357
    Colorectal Cancer
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Brain Tumor, Central Nervous System Tumor
    Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Epratuzumab and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Recurrent Childhood Acute Lymphoblastic Leukemia
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Brain and Central Nervous System Tumors
    TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
    Loma Linda University Medical Center

    Trial Locations
    Loma Linda University Medical Center
    LLU Faculty Medical Offices
    Ovarian Neoplasms
    Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain
    Loma Linda Center for Pain Management
    Loma Linda, California 92354
    Pain, Cancer
    Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin’s Lymphoma
    Loma Linda University
    Loma Linda, California 92354
    Lymphoma, Non-Hodgkin, Lymphoma, Low-Grade
    A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Diffuse Large-Cell Lymphoma
    A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
    Loma Linda University Cancer Institute
    Loma Linda, California 92354
    NSCLC
    Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Disseminated Neuroblastoma, Juvenile Myelomonocytic Leukemia, Previously Treated Childhood Rhabdomyosarcoma, Previously Treated Myelodysplastic Syndromes, Pulmonary Complications, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Neuroblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors, Recurrent/Refractory Childhood Hodgkin Lymphoma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Neuroblastoma
    Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Actinic Keratosis
    High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Sarcoma
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Loma Linda University Medical Center
    Loma Linda, California 92354
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    A Safety and Efficacy Study of Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
    Loma Linda Medical Center
    Loma Linda, California 92354
    Anesthesia, Surgical Procedures, Elective
    Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy
    VA Medical Center, Loma Linda
    Loma Linda, California 92357
    Rheumatoid Arthritis
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Leukemia
    Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus
    Loma Linda Cancer Institute
    Loma Linda, California 92354
    Mixed Tumor, Mullerian
    A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.
    Loma Linda University
    Loma Linda, California 92354
    Palliative Care, Pain, Cancer
    Zalutumumab in Non-curable Patients With SCCHN
    Loma Linda University Cancer Institute
    Loma Linda, California 92354
    Head and Neck Cancer, Squamous Cell Cancer
    Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen
    Sanofi-Aventis Investigational Site Number 840116
    Loma Linda, California 92354
    Colorectal Neoplasms, Neoplasm Metastasis
    Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Locally Advanced Non-Small Cell Lung Cancer
    Proton Beam Therapy for Treatment of Hepatocellular Carcinoma
    Loma Linda University Medical Center / James M. Slater Proton Treatment Center
    Loma Linda, California 92354
    Liver Cancer, Hepatocellular Carcinoma
    Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Severe Sepsis
    ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer
    Loma Linda University Cancer Center
    Loma Linda, California 92354
    Non-Small Cell Lung Cancer
    Safety and Efficacy of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease
    Loma Linda University Dept. of Loma Linda CancerCent
    Loma Linda, California 92354
    Symptomatic Refractory Resistant Carcinoid Disease
    Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma
    Loma Linda U Cancer Center
    Loma Linda, California 92354
    Relapsed Follicular Lymphoma
    Trial of Romidepsin and Bortezomib for Multiple Myeloma
    Loma Linda University Cancer Center
    Loma Linda, California 92354
    Multiple Myeloma
    In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis
    Loma Linda University

    Trial Locations
    Loma Linda University
    VA Loma Linda Health Care System
    Skin Cancer, Melanoma, Lentigo Maligna
    Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
    Loma Linda University Cancer Institute
    Loma Linda, California 92354
    Anemia, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small-Cell Lung, Bladder Cancer, Cancer of Head and Neck, Uterine Cervical Cancer
    Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer
    Loma Linda University Cancer Center
    Loma Linda, California 92354
    Melanoma, Metastatic Kidney Cancer
    Saliva, Hyperbaric Oxygen Therapy, & Gland Function: A Prospective Study
    Loma Linda University Health System
    Loma Linda, California 92354
    Osteoradionecrosis of the Jaw, Xerostomia
    Vismodegib for Treatment of Basal Cell Carcinoma
    Faculty Medical Offices
    Loma Linda, California 92354
    Basal Cell Carcinoma
    Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Gliosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Osteosarcoma